Earnings season wrap: Telstra feels competitive heat

Nicholas Grove/Glenn Freeman  |  17/02/2017Text size  Decrease  Increase  |  

Johannes Faul: The results beat consensus expectations by about 4.5 per cent which, was a positive takeaway. However, drilling down into the individual divisions, there were some misses and some beats that the divisions that have done really well over the past few halves have continued to outperform and that includes Kmart and particularly, Bunnings Australia and New Zealand. Also, the industrials division has done quite well.

Unfortunately, in our view, Coles has done less well, growing at 2.2 per cent versus our expectation for the year of 2.6 per cent and we actually saw the market overall growing in Australia by 2.9 per cent which implies that Coles lost market share to the other players. That basically underpins or strengthens our thesis that we published a few months ago on the Australian supermarket business where we see the incumbent supermarkets losing share but also seeing EBIT margins tightening and that's also another factor that we've seen at Coles today that EBIT margins are actually declining.

Bunnings has done better than what we thought in Australia and New Zealand. In the UK, Bunning is in still very early days. They haven't had the business for yet a year and only one pilot Bunnings store has been opened so far.

Another surprise in our view was Officeworks is on the chopping block and that adds another business to be sold including resources. So, what that means in our view is, intentionally or not, the conglomerate is being streamlined or dis-diversified with the potential sale of Officeworks and also the Coles assets and basically, they will focus management's attention to core businesses, which in our view, are really supermarkets and Bunnings followed by Kmart. So, for us, that will be a positive if those two businesses were sold.

Mathew Hodge: It was pretty much as expected. I mean, the company releases its quarterly production and cost numbers. So, there's no huge amount of play between that. So, it was largely as expected. They paid a final last year, but they've decided to pay an interim for the first time in quite a while. They had more ability to pay dividends; it's good that they are paying a dividend. So, that was a bit of a positive, but you don't exactly buy these stocks for the dividend. The yield is probably only going to be about 1 per cent. So, it's really just to play on the gold price. But if they've got extra cash, then they should return it to shareholders. I think it's a reasonable thing.

Chris Kallos: The CSL result was very strong. We knew that given the profit upgrade a couple of weeks ago, that we would have a good number on the immunoglobulin side, which has benefited from supply constraints of competitors in the US and also some new indications in Europe which are panning out very well. The real surprise in the result was how good the Seqirus division is doing. This you might remember is the division formed last year through the amalgamation of the Novartis flu vaccine assets. It is a loss-making division at the moment, but we think they are well on track to break even by 2018 and well on track to meet our target of $1-billion contribution by 2021. As we know, CSL is the largest stock in the index in the healthcare sector. But we particularly like the fact that they are well ahead of the competition in terms of supply. They have the most number of collection sites in the US and that provides great certainty on the supply side for the plasma-derived product business.

Brian Han: Telstra's first-half results fell slightly below our expectations. The competitive intensity in the market and the impact of the NBN and their effect on Telstra did catch us a little by surprise. That led to earnings declines across all of Telstra's core business units and the overall earnings only held up because of increasing payments from the NBN. Stepping back from the results, we are not too concerned about a six-month result. After all, the company did reaffirm full-year earnings guidance. Dividend payments are secure and Telstra is winning more than its fair share of customers in the various categories of the telecom market, including mobile, broadband and the NBN. Therefore, we thought yesterday's result, and the negative reaction to the result, was a bit harsh and we are still very positive on Telstra.

Video Archive...

Schroders stays hot on commodities, cooler on tech and defensives
01/05/2017  Long-term investors in Australian shares will continue to find value, but the time for risk-taking on more speculative plays has passed, says Martin Conlon, Schroders’ head of Australian equities
Introducing star ratings to Morningstar Australasia equity research
27/04/2017  What investors can expect from Morningstar's roll-out of its star rating methodology across Australian and New Zealand stocks, as explained by the regional director of equity research, Adam Fleck.
French elections: Macron versus Le Pen
26/04/2017  Following the first round of the French Presidential elections, the 7 May vote is now between Emmanuel Macron and Marine Le Pen. What does it mean for investors?
How climate change will impact your portfolio
20/04/2017  Ignore climate change at your portfolio's peril, says Jeremy Grantham, founder of asset manager GMO.
How dwindling resources will push up commodity prices
13/04/2017  Jeremy Grantham, renowned investor and founder of GMO, explains how a growing population is putting a strain on global resources.
How retirement spending affects withdrawal rates
10/04/2017  Data shows that the withdrawal rate gets higher as spending decreases in retirement, says Michael Kitces, a US-based financial planning expert.
What lies ahead for mining and materials
10/04/2017  Iron ore, coal, lithium, and uranium: some end-markets will rise and others will fall behind, says Morningstar commodities and resources analyst David Wang.
The evolution of multi-asset investing
07/04/2017  More difficult market conditions in a rising interest rate environment highlight the value of active management across your portfolio, says Simon Doyle, Schroders' head of fixed income and multi-asset.
When is the right time to buy stocks?
29/03/2017  Davis' Associates Chris Davis says the best time to invest is when you have the money, and to ignore market "noise".
How misinterpreting risk impacts financial returns
28/03/2017  Dr Gerd Gigerenzer says fund providers need to invest in education so that savers are better equipped to deal with risk--and can make better financial decisions.
Are European stocks overvalued?
27/03/2017  Isabel Levy of French asset manager Metropole Gestion explains how she uses fundamental industrial analysis to avoid value traps and identify the fair value of European equities.
Which funds are worth paying for?
23/03/2017  High active share funds--that is, those managers who take off-benchmark bets--outperform those which are low active share. So, ban closet trackers from your portfolio.
Bond market wobbles no cause for panic
21/03/2017  Australian bonds see only a slight tremor in response to the Fed's rate rise, says John Likos, Morningstar's senior credit analyst, who also provides insights on the new, and anticipated, hybrids from Australian banks.
ESG: Essential steps for successful long-term investing
21/03/2017  Want sustainable long-term returns? Morningstar UK reveals the essential components and the fund providers who are getting it right.
Few values left in global stock market
20/03/2017  Morningstar's directors of equity research think investors need to be cautious in the market today and offer some of their best investment ideas.
Why the time is right to invest in emerging markets
20/03/2017  Hilde Jenssen from Norwegian fund manager Skagen admits that emerging markets have disappointed investors over the past three years--but says valuations are attractive and reforms are boosting returns.
Johnson: Fed's path may not be smooth
16/03/2017  The Fed's plan for stair-step rate hikes in the coming years will likely be derailed by economic reality, says Morningstar's Bob Johnson.
First-half 2017 earnings season insights
15/03/2017  Companies produced reasonably good results overall with only a few standouts, even as a cost-out theme dominated, says Peter Warnes, head of equities research, Morningstar.
The growing appeal of LICs
06/03/2017  The popularity of listed investment companies is on the rise once again, but there are several things investors need to be aware of before buying in, explains Michael Malseed, Morningstar senior analyst, manager research.
Earnings season wrap: BHP exercises good cost control
27/02/2017  As the curtains close on the 1H17 reporting season, BHP books earnings that are slightly softer than expected, while Woolies takes market share at the expense of margins.